Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Registry Study for Radiation Therapy Outcomes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01255748
Recruitment Status : Recruiting
First Posted : December 7, 2010
Last Update Posted : April 18, 2022
Sponsor:
Information provided by (Responsible Party):
Proton Collaborative Group

Brief Summary:
The purpose of this research study is to collect and analyze information from patients being treated with various forms of radiation therapy.

Condition or disease Intervention/treatment
Solid Tumors Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 40000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 30 Years
Official Title: Evaluation Tracking Project: A Prospective Chart Review of Patients Treated With Radiation Therapy
Study Start Date : June 2009
Estimated Primary Completion Date : June 2039

Group/Cohort Intervention/treatment
Treatment with Radiation Therapy
Includes 16 different arms to capture patient data by disease site
Radiation: Proton Therapy, Photon Therapy, SRS, Brachytherapy
Outcomes Tracking




Primary Outcome Measures :
  1. Define outcomes for patients treated at participating institutions [ Time Frame: PRN ]

Secondary Outcome Measures :
  1. Determine strategies necessary to improve patients outcome and decrease toxicities related to treatments and procedures [ Time Frame: Annually PRN ]
  2. Improve patient care by an adequate understanding of the results and patient population at participating institutions [ Time Frame: Reviewed Annually PRN ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Radiation Oncology patients
Criteria

Inclusion Criteria:

  • Planned treatment with radiation therapy
  • Ability to understand and sign IRB approved consent

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255748


Contacts
Layout table for location contacts
Contact: Matthew Morocco 630-836-8670 mmorocco@pcgresearch.org

Locations
Show Show 17 study locations
Sponsors and Collaborators
Proton Collaborative Group
Investigators
Layout table for investigator information
Study Chair: Carlos Vargas, MD Proton Collaborative Group
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Proton Collaborative Group
ClinicalTrials.gov Identifier: NCT01255748    
Other Study ID Numbers: REG001-09
First Posted: December 7, 2010    Key Record Dates
Last Update Posted: April 18, 2022
Last Verified: April 2022
Keywords provided by Proton Collaborative Group:
cancer, proton, radiation